Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC.LXRX · Entity 4970 | Director | May 21, 2023 | May 22, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEXICON PHARMACEUTICALS, INC.
Report date May 21, 2023 · Filed May 22, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 41,046 |
Reported balance
After 2023-05-21 transaction · row 1
1 source rowRow 1 · 2023-05-21 · Exercise / conversion · Acquired 9,302 · Balance 41,046 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2023-05-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-05-21 · Exercise / conversion · Disposed 9,302 · Balance 0 F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2: Each restricted stock unit represents a contingent right to receive one share of common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2: Each restricted stock unit represents a contingent right to receive one share of common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2023 Filed May 22, 2023 20:05 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 9,302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-016434 · form4.xml · derivative · entry 2 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,302 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 21, 2023 Filed May 22, 2023 20:05 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 9,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-016434 · form4.xml · nonDerivative · entry 1 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2023 Filed Apr 28, 2023 20:25 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 12,658 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001127602-23-013785 · form4.xml · derivative · entry 2 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,658 Underlying: Common Stock · 12,658 shares Expires 2033-04-28 F3 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 28, 2023 Filed Apr 28, 2023 20:25 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 8,032 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-013785 · form4.xml · derivative · entry 1 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,032 Underlying: Common Stock · 8,032 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 9,302 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-015374 · form4.xml · derivative · entry 2 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,302 Underlying: Common Stock · 9,302 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| May 21, 2022 Filed May 23, 2022 20:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 14,402 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001127602-22-015374 · form4.xml · derivative · entry 1 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,402 Underlying: Common Stock · 14,402 shares Expires 2032-05-21 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012830 · form4.xml · derivative · entry 2 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,024 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 30, 2022 Filed May 2, 2022 20:16 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 4,024 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012830 · form4.xml · nonDerivative · entry 1 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:04 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 6,475 | $0.00 Strike: $5.04 | $0.00 |
DisclosureSEC source: 0001127602-21-014965 · form4.xml · derivative · entry 2 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,475 Underlying: Common Stock · 6,475 shares Expires 2031-04-30 F3 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 30, 2021 Filed May 3, 2021 21:04 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 4,024 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014965 · form4.xml · derivative · entry 1 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,024 Underlying: Common Stock · 4,024 shares Expires not disclosed F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:48 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 10,638 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014521 · form4.xml · derivative · entry 2 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 24, 2021 Filed Apr 27, 2021 20:48 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 10,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-014521 · form4.xml · nonDerivative · entry 1 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2020 Filed Apr 27, 2020 20:47 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionRestricted Stock Units · Derivative | 3,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014566 · form4.xml · derivative · entry 4 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,466 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 26, 2020 Filed Apr 27, 2020 20:47 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | Exercise / conversionCommon Stock | 3,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014566 · form4.xml · nonDerivative · entry 1 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,082 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 20:47 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 10,638 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014566 · form4.xml · derivative · entry 3 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,638 Underlying: Common Stock · 10,638 shares Expires not disclosed F2 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 20:47 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 18,115 | $0.00 Strike: $1.86 | $0.00 |
DisclosureSEC source: 0001127602-20-014566 · form4.xml · derivative · entry 2 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,115 Underlying: Common Stock · 18,115 shares Expires 2030-04-24 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 26, 2019 Filed Apr 29, 2019 21:06 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantRestricted Stock Units · Derivative | 3,466 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-016495 · form4.xml · derivative · entry 2 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,466 Underlying: Common Stock · 3,466 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| April 26, 2019 Filed Apr 29, 2019 21:06 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 6,519 | $0.00 Strike: $5.67 | $0.00 |
DisclosureSEC source: 0001127602-19-016495 · form4.xml · derivative · entry 1 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,519 Underlying: Common Stock · 6,519 shares Expires 2029-04-26 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| April 27, 2018 Filed Apr 27, 2018 21:39 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 2,857 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001127602-18-015449 · form4.xml · derivative · entry 2 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,857 Underlying: Common Stock · 2,857 shares Expires 2028-04-27 F1 · derivative.exercise_date: Option vests with respect to 1/12th of the shares subject to the option for each month of service following the date of grant. Read SEC document |
| April 27, 2018 Filed Apr 27, 2018 21:39 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantCommon Stock | 2,564 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-015449 · form4.xml · nonDerivative · entry 1 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,616 Read SEC document |
| April 28, 2017 Filed May 1, 2017 20:51 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantStock Option (Right to Buy) · Derivative | 2,857 | $0.00 Strike: $15.61 | $0.00 |
DisclosureSEC source: 0001127602-17-016066 · form4.xml · derivative · entry 2 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,857 Underlying: Common Stock · 2,857 shares Expires 2027-04-28 F1 · derivative.exercise_date: Option vests with respect to 1/12th of the shares subject to the option for each month of service following the date of grant. Read SEC document |
| April 28, 2017 Filed May 1, 2017 20:51 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | GrantCommon Stock | 1,281 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-016066 · form4.xml · nonDerivative · entry 1 NIES ALAN S · CIK 0001270260 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,052 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.